Annual Operating Margin
-1102.96%
+143.46%+11.51%
December 31, 2023
Summary
- As of February 21, 2025, CANF annual operating profit margin is -1102.96%, with the most recent change of +143.46% (+11.51%) on December 31, 2023.
- During the last 3 years, CANF annual operating margin has risen by +750.12% (+40.48%).
- CANF annual operating margin is now -678.21% below its all-time high of -141.73%, reached on December 31, 2018.
Performance
CANF Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
N/A
June 30, 2024
Summary
- CANF quarterly operating profit margin is not available.
Performance
CANF Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
CANF Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.5% | - |
| 3 y3 years | +40.5% | - |
| 5 y5 years | -678.2% | - |
CANF Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.7% | ||
| 5 y | 5-year | -86.7% | +40.5% | ||
| alltime | all time | -678.2% | +79.0% |
Can-Fite BioPharma Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -1102.96%(-11.5%) | -1183.23%(+24.4%) |
| Sep 2023 | - | -951.53%(+4.5%) |
| Jun 2023 | - | -910.20%(-34.2%) |
| Mar 2023 | - | -1383.67%(-11.6%) |
| Dec 2022 | -1246.42%(-17.2%) | -1564.97%(+24.1%) |
| Sep 2022 | - | -1261.27%(+24.3%) |
| Jun 2022 | - | -1014.71%(-12.2%) |
| Mar 2022 | - | -1156.10%(-41.4%) |
| Dec 2021 | -1505.51%(-18.8%) | -1974.51%(+41.2%) |
| Sep 2021 | - | -1398.41%(+11.6%) |
| Jun 2021 | - | -1253.20%(-14.6%) |
| Mar 2021 | - | -1466.89%(-38.1%) |
| Dec 2020 | -1853.08%(+213.6%) | -2368.67%(+101.6%) |
| Sep 2020 | - | -1174.88%(-37.4%) |
| Jun 2020 | - | -1877.94%(-13.0%) |
| Mar 2020 | - | -2159.60%(-10.1%) |
| Dec 2019 | -590.90%(+316.9%) | - |
| Dec 2019 | - | -2401.56%(+891.3%) |
| Sep 2019 | - | -242.27%(-67.4%) |
| Jun 2019 | - | -743.96%(+30.0%) |
| Mar 2019 | - | -572.24%(-33.9%) |
| Dec 2018 | -141.73% | - |
| Dec 2018 | - | -866.09%(-3635.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | 24.50%(-103.4%) |
| Jun 2018 | - | -728.52%(+189.9%) |
| Mar 2018 | - | -251.27%(-90.6%) |
| Dec 2017 | -910.65%(-82.7%) | - |
| Dec 2017 | - | -2672.94%(+1124.4%) |
| Sep 2017 | - | -218.31%(-91.6%) |
| Jun 2017 | - | -2586.76%(-8.1%) |
| Mar 2017 | - | -2814.71%(-25.3%) |
| Dec 2016 | -5262.42%(+35.1%) | - |
| Sep 2016 | - | -3770.20%(-3.4%) |
| Jun 2016 | - | -3902.46%(+34.1%) |
| Mar 2016 | - | -2909.82%(-67.0%) |
| Dec 2015 | -3894.56%(+283.7%) | - |
| Dec 2015 | - | -8826.74%(+333.4%) |
| Sep 2015 | - | -2036.67%(-0.7%) |
| Jun 2015 | - | -2052.04%(+99.9%) |
| Dec 2011 | -1015.01%(+101.0%) | - |
| Dec 2011 | - | -1026.53%(+16.5%) |
| Sep 2011 | - | -881.16%(-8.9%) |
| Jun 2011 | - | -967.34%(-18.4%) |
| Mar 2011 | - | -1185.88%(+60.8%) |
| Dec 2010 | -505.07% | - |
| Dec 2010 | - | -737.61%(+9.5%) |
| Sep 2010 | - | -673.84% |
FAQ
- What is Can-Fite BioPharma annual operating profit margin?
- What is the all time high annual operating margin for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual operating margin year-on-year change?
- What is the all time high quarterly operating margin for Can-Fite BioPharma?
What is Can-Fite BioPharma annual operating profit margin?
The current annual operating margin of CANF is -1102.96%
What is the all time high annual operating margin for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual operating profit margin is -141.73%
What is Can-Fite BioPharma annual operating margin year-on-year change?
Over the past year, CANF annual operating profit margin has changed by +143.46% (+11.51%)
What is the all time high quarterly operating margin for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly operating profit margin is 24.50%